Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Steyn

Showing results (131-140 of 168) with videos related to

Pageof 17
Sort By:
Bioorganic & Medicinal Chemistry Letters|January 14, 2015
Discovery of indole-derived pyridopyrazine-1,6-dione γ-secretase modulators that target presenilinMartin Pettersson, Douglas S Johnson, John M Humphrey, et al.
Journal of Medical Internet Research|April 17, 2025
The Use of Digital Devices to Monitor Physical Behavior in Motor Neuron Disease: Systematic ReviewLucy Samantha Musson, Nina Mitic, Victoria Leigh-Valero, et al.
Journal of Medical Internet Research|September 22, 2021
A Road Map for Remote Digital Health Technology for Motor Neuron DiseaseRuben P A van Eijk, Anita Beelen, Esther T Kruitwagen, et al.
Cancer Research|October 19, 2007
Discovery and pharmacologic characterization of CP-724,714, a selective ErbB2 tyrosine kinase inhibitorJitesh P Jani, Richard S Finn, Mary Campbell, et al.
Brain Communications|November 26, 2020
Altered skeletal muscle glucose-fatty acid flux in amyotrophic lateral sclerosisFrederik J Steyn, Rui Li, Siobhan E Kirk, et al.
Journal of Medicinal Chemistry|June 10, 2017
Design and Synthesis of γ- and δ-Lactam M<sub>1</sub> Positive Allosteric Modulators (PAMs): Convulsion and Cholinergic Toxicity of an M<sub>1</sub>-Selective PAM with Weak Agonist ActivityJennifer E Davoren, Michelle Garnsey, Betty Pettersen, et al.
Current Drug Metabolism|November 11, 2008
High throughput ADME screening: practical considerations, impact on the portfolio and enabler of in silico ADME modelsCornelis E C A Hop, Mark J Cole, Ralph E Davidson, et al.
Molecular Cancer Therapeutics|April 1, 2010
PF-03814735, an orally bioavailable small molecule aurora kinase inhibitor for cancer therapyJitesh P Jani, Joel Arcari, Vincent Bernardo, et al.
Computers in Biology and Medicine|July 29, 2025
Segmentation of the human tongue musculature using MRI: Field guide and validation in motor neuron diseaseThomas B Shaw, Fernanda L Ribeiro, Xiangyun Zhu, et al.
Neuropharmacology|July 19, 2011
Modulation of NMDA receptor function by inhibition of D-amino acid oxidase in rodent brainChristine A Strick, Cheryl Li, Liam Scott, et al.
Pageof 17

Showing results (131-140 of 168) with videos related to

Sort By:
Pageof 17
Bioorganic & Medicinal Chemistry Letters|January 14, 2015
Discovery of indole-derived pyridopyrazine-1,6-dione γ-secretase modulators that target presenilinMartin Pettersson, Douglas S Johnson, John M Humphrey, et al.
Journal of Medical Internet Research|April 17, 2025
The Use of Digital Devices to Monitor Physical Behavior in Motor Neuron Disease: Systematic ReviewLucy Samantha Musson, Nina Mitic, Victoria Leigh-Valero, et al.
Journal of Medical Internet Research|September 22, 2021
A Road Map for Remote Digital Health Technology for Motor Neuron DiseaseRuben P A van Eijk, Anita Beelen, Esther T Kruitwagen, et al.
Cancer Research|October 19, 2007
Discovery and pharmacologic characterization of CP-724,714, a selective ErbB2 tyrosine kinase inhibitorJitesh P Jani, Richard S Finn, Mary Campbell, et al.
Brain Communications|November 26, 2020
Altered skeletal muscle glucose-fatty acid flux in amyotrophic lateral sclerosisFrederik J Steyn, Rui Li, Siobhan E Kirk, et al.
Journal of Medicinal Chemistry|June 10, 2017
Design and Synthesis of γ- and δ-Lactam M<sub>1</sub> Positive Allosteric Modulators (PAMs): Convulsion and Cholinergic Toxicity of an M<sub>1</sub>-Selective PAM with Weak Agonist ActivityJennifer E Davoren, Michelle Garnsey, Betty Pettersen, et al.
Current Drug Metabolism|November 11, 2008
High throughput ADME screening: practical considerations, impact on the portfolio and enabler of in silico ADME modelsCornelis E C A Hop, Mark J Cole, Ralph E Davidson, et al.
Molecular Cancer Therapeutics|April 1, 2010
PF-03814735, an orally bioavailable small molecule aurora kinase inhibitor for cancer therapyJitesh P Jani, Joel Arcari, Vincent Bernardo, et al.
Computers in Biology and Medicine|July 29, 2025
Segmentation of the human tongue musculature using MRI: Field guide and validation in motor neuron diseaseThomas B Shaw, Fernanda L Ribeiro, Xiangyun Zhu, et al.
Neuropharmacology|July 19, 2011
Modulation of NMDA receptor function by inhibition of D-amino acid oxidase in rodent brainChristine A Strick, Cheryl Li, Liam Scott, et al.
Pageof 17